Late Stage Reference Material
RFM 2025 — Follow-up RFM conference for establishing In House References for Commercial Products. This is a topic which was suggested multiple times by attendees of the virtual early stage RFM meeting held June 2024. We are suggesting this to complete the information available to drug sponsors to enable more efficient and compliant establishment of in-house reference programs.
